GovChime
AWARDDELIVERY ORDEROther than small business

Delivery order 75N95020F00001LOVELACE BIOMEDICAL RESEARCH INSTITUTE

Overview

Award facts

Net obligations
$5.30M
$5,298,497of $8.10M potential value
Outlays (paid to date)
$1.22M
$1.22M paid of $5.30M obligated$1,216,952
Period of performance
Sep 25, 2020 to May 31, 2027
Ends in 6 months
Modifications
7
Latest action May 29, 2026
Contract type
Delivery order
PIID 75N95020F00001

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

NON-CLINICAL SAFETY ASSESSMENT OF GENE THERAPY (PCCA, MMAB, DOK7 AND COLQ) TO SUPPORT PLATFORM GENE THERAPY FOR CONGENITAL MYASTHENIC DISEASES (DOK7, COLQ) AND ACIDEMIA (PCCA, MMAB)

Dates and value

Award date
Signed on Sep 23, 2020
Current value
$5,298,497Base and exercised options
Potential value (if all options are exercised)
$8,098,466
Parent contract vehicle
HHSN271201700017I (IDC, multiple award) — 3 orders recorded under it

Obligations by fiscal year of action

  • FY2026: $1,282,991
  • FY2025: $1,745,514
  • FY2020: $2,269,992

Total across 3 fiscal years: $5,298,497

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded May 29, 2026. View on USAspending · Recipient on SAM.gov

Recipient

LocationALBUQUERQUE, NM
UEIMBT9RXJJ7428
CAGE code3MMH4
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate tax exempt

Business types and certifications

Tax-exempt corporation

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIDA
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIDA
Funded from
National center for advancing translational sciences (0875)Program activities075-0875Federal accounts (agency financial reports)

Place of performance

Place of performance
Albuquerque, Bernalillo County, New Mexico 87108-5129
Congressional district (place of performance)
NM-01As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Subject to multiple award fair opportunityMAFO
Set-aside
No set-aside used
Contract pricing
Cost plus fixed feeU
Offers received
3

Solicitation and notices

Solicitation ID
N01TR-17-2002-19(as reported)
Solicitation date
Jul 24, 2020

Contract details

Subcontracting plan
Individual subcontract planF
Major program
Cro support for ncats in vitro and in vivo toxicology studies
Certified cost or pricing data
No
Service Contract Act labor standards
No
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Sep 23, 2020Base obligation at award: $2,269,992
Latest action
May 29, 2026 — Supplemental agreement (within scope)Modification P00007; obligation change +$1,282,991
Latest substantive action
May 29, 2026 — Supplemental agreement (within scope)Modification P00007; obligation change +$1,282,991
Actions by type
  • Base award1
  • Supplemental agreement (within scope)5
  • Change order1
  • Option exercised1
8 actions recorded, Sep 23, 2020 to May 29, 2026; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
$1,282,991
Latest action: change in base and all options
$1,282,991

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No
Construction wage rates (Davis-Bacon)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Delivery orderC
Parent vehicle type
IDCB
Parent vehicle: multiple or single award
Multiple awardM
Parent vehicle agency
National Institutes Of Health7529
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N950
Transactions recorded under this award key
8

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N950
Treasury accounts
  • 075-2020/2020-0875-000
  • 075-2025/2025-0875-000
Object classes
  • 25.1: Advisory and assistance services
  • 25.2: Other services from non-Federal sources
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression